Pharmacy Practice Faculty Publications


Elucidation of Aberrant Purine Metabolism: Application to Hypoxanthine-Guanine Phosphoribosylstransferase- and Adenosine Kinase-deficient Mutants, and IMP Dehydrogenase- and Adenosine Deaminase-inhibited Human Lymphoblasts

Document Type


Publication Date


Journal Title

Biochimica et Biophysica Acta (BBA) - Nucleic Acids and Protein Synthesis







First Page


Last Page



PubMed ID



We propose that the ratio of [14C]formate-labelled purine nucleosides and bases (both intra and extracellular) to nucleic acid purines provides, in exponentially growing cultures, a sensitive index for comparative studies of purine metabolism. This ratio was 4-fold greater for an HGPRT− mutant than for the parental HGPRT+ human lymphoblast line. The major components of the labelled nucleoside and base fraction were hypoxanthine and inosine. By blocking adenosine deaminase activity with coformycin we found that approx. 90% of inosine was formed directly from IMP rather than the route IMP → AMP → adenosine → inosine. The ratio of labelled base + nucleosides to nucleic acids was essentially unchanged for an AK− lymphoblast line and 2-fold greater than control for an HGPRT−-AK− line, demonstrating that a deficiency of adenosine kinase alone has little effect on the accumulation of purine nucleosides and bases. Although adenosine was a minor component of the nucleoside and base fraction, the adenosine fraction increased from 3 to 13% with the addition of coformycin to the HGPRT−-AK− line. In the parental and HGPRT− lines, adenosine was shown to be primarily phosphorylated rather than deaminated at concentrations less than 5 μM. Inhibition of IMP dehydrogenase activity by mycophenolic acid caused a 12- and 3-fold increase in the rate of production of labelled base and nucleoside in the parent and HGPRT− cells respectively. These results suggest that a mutationally induced partial deficiency in the activities converting IMP to guanine nucleotides may result in an increased catabolism of IMP.


Purine metabolism, hypoxanthine-guanine phosphoribosyltransferase deficiency, adenosine kinase deficiency, IMP dehydrogenase inhibition, adenosine deaminase inhibition, human lymphoblast